SmartLabs has signed a 140,000-square-foot lease to convert the third floor of the CambridgeSide mall into lab space. This addition increases SmartLabs’ Greater Boston footprint by 75%. It also provides fractionalized access to lab spaces and will enable programs of all sizes to move their discoveries to clinical trials under one platform. It prevents construction waste and is environmentally and fiscally responsible.
We are excited to bring our advanced capabilities to CambridgeSide and to expand our national network of labs and manufacturing centers that will scale up and scale out personalized medicine and other novel therapies, said Amrit Chaudhuri, CEO and co-founder of SmartLabs in a statement.
Initially, New England Development planned to convert the space into offices but shifted its focus due to remote work. They hope to land a tenant or two soon at 20 CambridgeSide, a 10-story, 365,000-square-foot life sciences complex set to be built at the mall by late 2023.
We are seeing a little bit of a pickup now,” Douglass Karp, president of New England Development, told the Boston Business Journal. “It’s not back to the furious pace it might have been 12 to 18 months ago, but we’re getting interest in 20 CambridgeSide and we’re excited about that, and looking to land a tenant or two there sooner rather than later.
